Advanced Neural Biosciences
Advanced Neural Biosciences, Inc. (ANB) is an American biomedical research company located in Portland, Oregon and Brooklyn, New York.[2] Founded in late 2008,[3] its aim is to perfect low temperature technologies to preserve central nervous tissue and whole brains for brain banking, pharmacological drug discovery, and the study of neurodegenerative diseases.[2] Another focus of the company is the development of novel compounds to restore optimal blood flow to the brain after stroke and cardiac arrest.[2]
ANB's president is Chana Phaedra, and the chief executive officer is Aschwin de Wolf.[4]
ANB has received funding and equipment from the Immortalist Society, the Life Extension Foundation, the Cryonics Institute, and the Alcor Life Extension Foundation.[5] ANB collaborates with Alcor on a variety of research projects.[6]
Sources[править]
- ↑ PROFILE: ASCHWIN DE WOLF. biostasis.com
- ↑ 2,0 2,1 2,2 Official website
- ↑ Advanced Neural Biosciences (page 17). Cryonics 2015 #4
- ↑ Contact. advancedneuralbio.com
- ↑ Human Cryopreservation Research at Advanced Neural Biosciences. Aschwin de Wolf & Chana Phaedra. immortalistsociety.org
- ↑ Advanced Neural Biosciences is hiring. alcor.org. January 26, 2015
External links[править]
- Official website
- Advanced Neural Biosciences (pages 17–20). Cryonics 2015 #4
- Human Cryopreservation Research at Advanced Neural Biosciences. Aschwin de Wolf & Chana Phaedra. immortalistsociety.org
- LinkedIn: Chana Phaedra
- LinkedIn: Aschwin de Wolf